ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 662,30
-0,58%
Dow Jones
39 112,16
-0,76%
DAX
18 177,62
-0,90%
Brent Oil
84,185
-1,27%
Bitcoin
61 949,14
2,80%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Corvus Pharmaceuticals Inc (CRVS)

  7. Corvus Pharmaceuticals Inc (CRVS) Actualités

CRVS Corvus Pharmaceuticals Inc

1,78
-0,05 (-2,73%)
Après les heures de négociation
Dernière mise à jour : 23:59:00
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Corvus Pharmaceuticals Inc CRVS NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
-0,05 -2,73% 1,78 23:59:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
1,84 1,78 1,90 1,78 1,83
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
17/6/202422:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/6/202422:15EDGAR2Form 8-K - Current report
30/5/202422:02GLOBECorvus Pharmaceuticals to Present at the Jefferies Global..
07/5/202423:19EDGAR2Form S-8 - Securities to be offered to employees in employee..
07/5/202423:16EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/5/202423:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/5/202422:11EDGAR2Form 8-K - Current report
06/5/202422:01EDGAR2Form 8-K - Current report
06/5/202422:01GLOBECorvus Pharmaceuticals Provides Business Update and Reports..
02/5/202422:02GLOBECorvus Pharmaceuticals to Provide Business Update and First..
02/5/202414:30GLOBECorvus Pharmaceuticals Announces Pricing of $30.6 Million..
09/4/202422:01GLOBECorvus Pharmaceuticals Announces Initiation of..
19/3/202421:02GLOBECorvus Pharmaceuticals Provides Business Update and Reports..
19/3/202412:27IHMARKETNEWSUS Index Futures Decline Ahead of Federal Reserve Meeting,..
13/3/202421:02GLOBECorvus Pharmaceuticals to Provide Business Update and Fourth..
01/3/202423:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/2/202414:30GLOBECorvus Pharmaceuticals Presents Soquelitinib Preclinical..
08/2/202422:27EDGAR2Form 3 - Initial statement of beneficial ownership of..
08/2/202422:05GLOBECorvus Pharmaceuticals Announces Orphan Drug Designation..
06/2/202422:05GLOBECorvus Pharmaceuticals Appoints Jeffrey Arcara as Chief..
23/1/202423:00EDGAR2Form 8-K - Current report
23/1/202423:00GLOBECorvus Pharmaceuticals Announces the Passing of Board Member..
09/12/202318:00GLOBECorvus Pharmaceuticals Presents New Interim Soquelitinib..
08/12/202322:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/12/202322:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/11/202322:03EDGAR2Form 8-K - Current report
07/11/202322:02EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202322:01GLOBECorvus Pharmaceuticals Provides Business Update and Reports..
02/11/202314:15GLOBECorvus Pharmaceuticals to Present New Interim Soquelitinib..
02/11/202300:31GLOBECorvus Pharmaceuticals Announces Publication of Preclinical..
31/10/202321:02GLOBECorvus Pharmaceuticals to Provide Business Update and Report..
06/9/202322:05GLOBECorvus Pharmaceuticals Confirms Planned Initiation of..
08/8/202322:02EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202322:01EDGAR2Form 8-K - Current report
08/8/202322:01GLOBECorvus Pharmaceuticals Provides Business Update and Reports..
01/8/202314:30GLOBECorvus Pharmaceuticals to Provide Business Update and Report..
06/7/202318:59GLOBECorvus Pharmaceuticals Announces Publication of Preclinical..
29/6/202313:00GLOBECorvus Pharmaceuticals Presents New Ciforadenant Preclinical..

Dernières Valeurs Consultées

NASDAQ
CRVS
Corvus Pharmaceuticals
USOTC
CCOOF
Core Assets (QB)
NASDAQ
MAXY
ASX
CBAHX
Commonwealth Bank of Aus...
NYSE
AGM-C
Federal Agricultural Mor...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés